Skip to content

Wednesday, December 23rd, 2009

BioCurex’s Novel Test Using Their Patented RECAF™ Technology, May Detect Cancer Earlier, Surpassing Other Tests Available

November 3, 2006 by Gloria Gamat  
Filed under Diseases & Conditions

BioCurex’s Novel Test Using Their Patented RECAF™ Technology, May Detect Cancer Earlier, Surpassing Other Tests Available

BioCurex is a cancer research and development company that has developed a method of cancer detection surpassing others in the field with the use of their patented RECAF™ technology.
With the said test, scientists at BioCurex can differentiate cancer cells from healthy cells in ways that previous scientists have been unable to do.
According to Dr. Moro-Vidal, BioCurex’s President and CEO:
“Cancer markers help distinguish cancer cells from non-cancerous cells. The ideal marker is a molecule that’s present in all cancer cells of all tissue types — none of the present markers can do that; and RECAF is the only one discovered to …read more


About Us | Advertise with us | Blog for Blisstree | Privacy Policy | Terms of Use
Get This Theme | Sitemap


All content is Copyright © 2005-2009 b5media. All rights reserved.